| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 1,279 | 775 |
| Total revenues | 920 | - |
| Purchases and related costs | 245 | - |
| Field operating costs | 190 | - |
| General and administrative expenses | 36 | - |
| Depreciation and amortization | 57 | - |
| (gains)/losses on asset sales, net | -15 | - |
| Total costs and expenses | 543 | - |
| Income from discontinued operations before tax | 377 | - |
| Current income tax expense | 61 | - |
| Deferred income tax (expense)/benefit | 35 | - |
| Income from discontinued operations, net of tax | 281 | 206 |
| Depreciation and amortization | 696 | 466 |
| (gains)/losses on asset sales, net | 64 | -29 |
| Deferred income tax expense | 65 | 40 |
| (gain)/loss on foreign currency revaluation | -19 | -4 |
| Settlement of terminated interest rate hedging instruments (note 8) | -7 | 0 |
| Equity earnings in unconsolidated entities | 292 | 196 |
| Distributions on earnings from unconsolidated entities | 369 | 256 |
| Gain on investments in unconsolidated entities, net (note 12) | 31 | 31 |
| Other | -48 | -32 |
| Changes in assets and liabilities, net of acquisitions | -18 | 140 |
| Cash provided by operating activities - continuing operations | 1,833 | 1,029 |
| Cash provided by operating activities - discontinued operations | 314 | 301 |
| Net cash provided by operating activities | 2,147 | 1,330 |
| Cash paid in connection with acquisitions, net of cash acquired | 865 | 681 |
| Investments in unconsolidated entities | 0 | 0 |
| Additions to property, equipment and other | 495 | 310 |
| Cash paid for purchases of linefill | 17 | 17 |
| Proceeds from sales of assets | 27 | 21 |
| Other investing activities | 0 | 0 |
| Cash used in investing activities - continuing operations | -1,350 | -987 |
| Cash used in investing activities - discontinued operations | -151 | -106 |
| Net cash used in investing activities | -1,501 | -1,093 |
| Net repayments under paa commercial paper program (note6) | -393 | 69 |
| Proceeds from the issuance of paa senior notes (note6) | 2,246 | 998 |
| Repurchase of common units by a subsidiary | 8 | 8 |
| Repurchase of series a preferred units by a subsidiary (note 7) | 333 | 333 |
| Distributions paid to classa shareholders (note7) | 225 | 150 |
| Distributions paid to noncontrolling interests (note7) | 1,087 | 731 |
| Contributions from noncontrolling interests | 34 | 29 |
| Other financing activities | -61 | -19 |
| Net cash provided by/(used in) financing activities | 173 | -145 |
| Effect of translation adjustment - continuing operations | 13 | 8 |
| Effect of translation adjustment - discontinued operations | 0 | 11 |
| Net increase in cash and cash equivalents and restricted cash | 832 | 111 |
| Cash and cash equivalents at beginning of period | 349 | - |
| Cash and cash equivalents at end of period | 1,181 | - |
PLAINS GP HOLDINGS LP (PAGP)
PLAINS GP HOLDINGS LP (PAGP)